Catalent has formed an advisory board to strategically shape growth of the company’s biologics business. Founding members of the advisory board are Carolyn Bertozzi, Barry Buckland, Michael Buckley, Daniel Marshak and Edward Robinson. “This new board brings diverse expertise in biologics development and commercialization, new technologies, contract services and a deep understanding of the key challenges facing biologics developers, both now and in the future,” said Mike Riley, vice preside...